Gefitinib and lung infiltration Patient Reports February 09, 2010

Gefitinib Side Effects Report #4553303-4
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, 37 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, lung infiltration, performance status decreased, pyrexia, weight decreased, white blood cell count increased. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4568279-3
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 21, 2005. Male patient, 37 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: lung infiltration, performance status decreased, pneumonia bacterial, pneumonitis, weight decreased. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4625603-0
Gefitinib side effect was reported by a Health Professional from on Mar 31, 2005. Male patient, weighting 222.2 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: back pain , bronchopulmonary disease, crepitations, haemoptysis, lung abscess, lung infiltration, pulmonary embolism , pyrexia. Gefitinib dosage: 1000 MG PO QD. During the same period patient was treated with RAPAMUNE, PRILOSEC, CARBATROL, EFFEXOR, MINOCYLCIN, DECADRON. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4975312-3
Gefitinib side effect was reported by a Health Professional from UNITED STATES on Apr 17, 2006. Male patient, weighting 273.2 lb, was diagnosed with glioblastoma multiforme and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, lung infiltration, oxygen saturation decreased, pneumocystis jiroveci pneumonia. Gefitinib dosage: 500 MG PO QD. During the same period patient was treated with RAPAMUNE, AVALIDE, DECADRON, KEPPRA, PEPCID, LOVENOX, MAGIC MOUTHWASH, PHENERGAN. Patient was hospitalized. Patient recovered.